NCT01743287View on ClinicalTrials.gov

The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

PHASE4CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Imotun capsule

Imotun capsule: Avocado-Soya Unsaponifiables 300.03mg/Cap, per oral, a capsule once a day during for 24 weeks

DRUG

Imotun capsule placebo

Imotun capsule placebo: per oral, a capsule a day during 24 weeks

Trial Locations (10)

Unknown

Chungbuk National University Hospital, Cheongju-si

633-165

Inje University Busan Paik Hospital, Busan

700-721

Kyungpook National University Hospital, Daegu

519-763

Chonnam National University Hwasun hospital, Hwasun

561-712

Chonbuk National University Hospital, Jeonju

463-712

Bundang CHA medical center, Seongnam

110-744

Seoul National University Hospital, Seoul

130-872

KyungHee University Medical Center, Seoul

135-710

Samsung Medical Center, Seoul

138-736

ASAN Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY